Trials
Search / Trial NCT05659485

Measuring Family Engagement in Care (The FAME Study)

Launched by LADY DAVIS INSTITUTE · Dec 12, 2022

Trial Information

Current as of January 16, 2025

Recruiting

Keywords

Family Engagement Family Engagement Family Centered Care Measures Instruments Intensive Care Unit

ClinConnect Summary

The FAME Study is researching how families can be more involved in the care of their loved ones in the intensive care unit (ICU). Right now, there isn't a reliable way to measure family engagement in these high-stress situations, so the study is developing a new tool called the FAMily Engagement (FAME) instrument. This study aims to understand how family involvement can improve outcomes for patients and to see how different factors, like age and relationship to the patient, may affect family engagement in the ICU.

To participate in this study, you need to be a family member of a patient who is currently in the ICU, be at least 18 years old, and be able to communicate in English or French. If you meet these criteria and are interested, you can expect to share your experiences and thoughts about your involvement in your loved one’s care. This research is important as it aims to improve the support families receive when their loved ones are critically ill, ultimately enhancing the overall care experience in the ICU.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Family member of patient admitted to the intensive care units
  • Able to participate in English or French
  • Age 18 years old or older
  • Exclusion Criteria:
  • ICU stays less than 24 hours
  • Another family member has already participated in the study

Trial Officials

Michael J Goldfarb, MD MSc

Principal Investigator

Lady Davis Institute

About Lady Davis Institute

The Lady Davis Institute (LDI) is a leading Canadian research organization dedicated to advancing health sciences through innovative clinical trials and translational research. Affiliated with the Jewish General Hospital in Montreal, LDI focuses on a multidisciplinary approach to understanding disease mechanisms and developing effective therapies. With a commitment to improving patient outcomes, the institute collaborates with academic institutions and industry partners to drive breakthroughs in areas such as cancer, cardiovascular health, and chronic diseases. Through its rigorous research programs and adherence to ethical standards, the Lady Davis Institute aims to contribute significantly to the global scientific community and enhance the quality of healthcare.

Locations

Toronto, Ontario, Canada

Calgary, Alberta, Canada

Montreal, Quebec, Canada

Montréal, Quebec, Canada

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials